Home/Pipeline/Benzodiazepine Plus

Benzodiazepine Plus

Urine Drug Test

In DevelopmentActive

Key Facts

Indication
Urine Drug Test
Phase
In Development
Status
Active
Company

About Ark Diagnostics

Ark Diagnostics is a commercial-stage diagnostics company with a core focus on homogeneous enzyme immunoassay technology for clinical chemistry analyzers. The company has established a diversified portfolio of ready-to-use liquid assays, primarily serving hospital and reference laboratories for therapeutic drug monitoring and forensic/clinical urine drug testing. Its strategy involves continuous assay development, with recent launches in ethyl glucuronide, ketamine, and methotrexate testing, and a pipeline expanding into areas like veterinary diagnostics and oral anticoagulants. Ark operates globally through a distributor network and maintains a presence at key scientific conferences.

View full company profile

Other Urine Drug Test Drugs

DrugCompanyPhase
BuprenorphineArk DiagnosticsIn Development